OMNi-BiOTiC 10 probiotic

OMNi-BiOTiC 10 is a premium probiotic supplement produced by Institut Allergosan, a company based in Graz, Austria. Founded in 1991, the brand was built on the research of Anita Frauwallner and focuses on highly active bacterial strains to support gut health, particularly during antibiotic treatment. The product is primarily manufactured in Austria, adhering to high pharmaceutical quality standards.

Historically an independent family-owned business, Institut Allergosan (the parent of OMNi-BiOTiC) was acquired in 2023 by the Swedish healthcare company Karo Healthcare AB. Karo Healthcare is headquartered in Stockholm and is itself owned by the private equity firm EQT Partners. Today, OMNi-BiOTiC remains a leading brand in the European probiotic market, managed under Karo's extensive consumer health portfolio.